BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 36792381)

  • 21. Antidepressants for cocaine dependence.
    Lima MS; Reisser AA; Soares BG; Farrell M
    Cochrane Database Syst Rev; 2001; (4):CD002950. PubMed ID: 11687168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.
    Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB
    J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug repurposing for reducing the risk of cataract extraction in patients with diabetes mellitus: integration of artificial intelligence-based drug prediction and clinical corroboration.
    Gao Z; Gorenflo M; Kaelber DC; Monnier VM; Xu R
    Front Pharmacol; 2023; 14():1181711. PubMed ID: 37274099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medications to treat cocaine use disorders: current options.
    Buchholz J; Saxon AJ
    Curr Opin Psychiatry; 2019 Jul; 32(4):275-281. PubMed ID: 31008728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Machine Learning Analysis of Cocaine Addiction Informed by DAT, SERT, and NET-Based Interactome Networks.
    Feng H; Gao K; Chen D; Shen L; Robison AJ; Ellsworth E; Wei GW
    J Chem Theory Comput; 2022 Apr; 18(4):2703-2719. PubMed ID: 35294204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ibrutinib as a potential therapeutic for cocaine use disorder.
    Huggett SB; Hatfield JS; Walters JD; McGeary JE; Welsh JW; Mackay TFC; Anholt RRH; Palmer RHC
    Transl Psychiatry; 2021 Dec; 11(1):623. PubMed ID: 34880215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of plasma-free endocannabinoids and their congeners in abstinent cocaine addicts seeking outpatient treatment: impact of psychiatric co-morbidity.
    Pavón FJ; Araos P; Pastor A; Calado M; Pedraz M; Campos-Cloute R; Ruiz JJ; Serrano A; Blanco E; Rivera P; Suárez J; Romero-Cuevas M; Pujadas M; Vergara-Moragues E; Gornemann I; Torrens M; de la Torre R; Rodríguez de Fonseca F
    Addict Biol; 2013 Nov; 18(6):955-69. PubMed ID: 24283982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GABAergic polygenic risk for cocaine use disorder is negatively correlated with precuneus activity during cognitive control in African American individuals.
    Yang BZ; Balodis IM; Kober H; Worhunsky PD; Lacadie CM; Gelernter J; Potenza MN
    Addict Behav; 2021 Mar; 114():106695. PubMed ID: 33153773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysregulation of Plasma Growth Factors and Chemokines in Cocaine Use Disorder: Implications for Dual Diagnosis with Schizophrenia and Antisocial Personality Disorder in an Exploratory Study.
    Torres-Galván S; Flores-López M; Ochoa E; Requena-Ocaña N; Araos P; Herrera-Imbroda J; Muga R; Serrano A; Rodríguez de Fonseca F; Pavón-Morón FJ; Haro G; García-Marchena N
    Neuropsychobiology; 2024; 83(2):73-88. PubMed ID: 38768577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders.
    García-Marchena N; Barrera M; Mestre-Pintó JI; Araos P; Serrano A; Pérez-Mañá C; Papaseit E; Fonseca F; Ruiz JJ; Rodríguez de Fonseca F; Farré M; Pavón FJ; Torrens M
    PLoS One; 2019; 14(3):e0213791. PubMed ID: 30870525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized placebo-controlled trial of galantamine in individuals with cocaine use disorder.
    DeVito EE; Carroll KM; Babuscio T; Nich C; Sofuoglu M
    J Subst Abuse Treat; 2019 Dec; 107():29-37. PubMed ID: 31757262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WITHDRAWN: Antidepressants for cocaine dependence.
    Silva de Lima M; Farrell M; Lima Reisser AA; Soares B
    Cochrane Database Syst Rev; 2010 Feb; (2):CD002950. PubMed ID: 20166064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin Transporter and Plasma Membrane Monoamine Transporter Are Necessary for the Antidepressant-Like Effects of Ketamine in Mice.
    Bowman MA; Vitela M; Clarke KM; Koek W; Daws LC
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review.
    du Jardin KG; Müller HK; Elfving B; Dale E; Wegener G; Sanchez C
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():27-38. PubMed ID: 27262695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ketamine-50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms.
    Kohtala S
    Pharmacol Rep; 2021 Apr; 73(2):323-345. PubMed ID: 33609274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapeutic strategies for treating cocaine use disorder-what do we have to offer?
    Brandt L; Chao T; Comer SD; Levin FR
    Addiction; 2021 Apr; 116(4):694-710. PubMed ID: 32888245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, double-blind, placebo-controlled trial of ondansetron for the treatment of cocaine use disorder with post hoc pharmacogenetic analysis.
    Blevins D; Seneviratne C; Wang XQ; Johnson BA; Ait-Daoud N
    Drug Alcohol Depend; 2021 Nov; 228():109074. PubMed ID: 34600264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular genetics of cocaine use disorders in humans.
    Fernàndez-Castillo N; Cabana-Domínguez J; Corominas R; Cormand B
    Mol Psychiatry; 2022 Jan; 27(1):624-639. PubMed ID: 34453125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.